Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT01089127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease, Using Salmeterol as an Active Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol.
Study identification
- NCT ID
- NCT01089127
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 552 participants
Conditions and interventions
Conditions
Interventions
- Indacaterol Drug
- Salmeterol 50 μg Drug
- Placebo to indacaterol Drug
- Placebo to salmeterol Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Aug 19, 2011
2010
United States locations
- U.S. sites
- 69
- U.S. states
- 28
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigator Site | Florence | Alabama | 35630 | — |
| Novartis Investigator Site | Jasper | Alabama | 35501 | — |
| Novartis Investigator Site | Phoenix | Arizona | 85006 | — |
| Novartis Investigator Site | Searcy | Arkansas | 72143 | — |
| Novartis Investigator Site | Fullerton | California | 92835 | — |
| Novartis Investigative Site | Rancho Mirage | California | 92270 | — |
| Novartis Investigator Site | Riverside | California | 92506 | — |
| Novartis Investigator Site | San Diego | California | 92120 | — |
| Novartis Investigator Site | Stockton | California | 95207 | — |
| Novartis Investigator Site | Temecula | California | 92591 | — |
| Novartis Investigator Site | Walnut Creek | California | 94598 | — |
| Novartis Investigator Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Glastonbury | Connecticut | 06033 | — |
| Novartis Investigative Site | Stamford | Connecticut | 06902 | — |
| Novartis Investigator Site | Clearwater | Florida | 33765 | — |
| Novartis Investigator Site | DeFuniak Springs | Florida | 32435 | — |
| Novartis Investigative Site | Hollywood | Florida | 33021 | — |
| Novartis Investigator Site | Miami | Florida | 33145 | — |
| Novartis Investigative Site | Pensacola | Florida | 32503 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Tamarac | Florida | 33321 | — |
| Novartis Investigator Site | Tampa | Florida | 33603 | — |
| Novartis Investigator Site | O'Fallon | Illinois | 62269 | — |
| Novartis Investigator Site | Florence | Kentucky | 41017 | — |
| Novartis Investigator Site | Madisonville | Kentucky | 42431 | — |
| Novartis Investigator Site | Opelousas | Louisiana | 70570 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigator Site | Edina | Minnesota | 55435 | — |
| Novartis Investigator Site | Fridley | Minnesota | 55432 | — |
| Novartis Investigator Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigator Site | Ozark | Missouri | 65721 | — |
| Novartis Investigator Site | St Louis | Missouri | 63141 | — |
| Novartis Investigator Site | Bellevue | Nebraska | 68123 | — |
| Novartis Investigator Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigator Site | Henderson | Nevada | 89014 | — |
| Novartis Investigator Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigator Site | Las Vegas | Nevada | 89183 | — |
| Novartis Investigator Site | Lebanon | New Hampshire | 03756 | — |
| Novartis Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Novartis Investigative Site | Bayside | New York | 11361 | — |
| Novartis Investigative Site | Great Neck | New York | 11023 | — |
| Novartis Investigative Site | Lake Success | New York | 11042 | — |
| Novartis Investigative Site | Larchmont | New York | 10538 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28152 | — |
| Novartis Investigator Site | Cadiz | Ohio | 43907 | — |
| Novartis Investigator Site | Canton | Ohio | 44718 | — |
| Novartis Investigator Site | Columbus | Ohio | 43215 | — |
| Novartis Investigator Site | Toledo | Ohio | 43608 | — |
| Novartis Investigative Site | Eugene | Oregon | 97404 | — |
| Novartis Investigator Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Phoenixville | Pennsylvania | 19460 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243 | — |
| Novartis Investigative site | Charleston | South Carolina | 29406-7108 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29407 | — |
| Novartis Investigative Site | Easley | South Carolina | 29640 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Novartis Investigative Site | Union | South Carolina | 29379 | — |
| Novartis Investigator Site | Cookeville | Tennessee | 38501 | — |
| Novartis Investigator Site | Dickinson | Texas | 77539 | — |
| Novartis Investigator Site | Fort Worth | Texas | 76104 | — |
| Novartis Investigator Site | McKinney | Texas | 75069 | — |
| Novartis Investigator Site | Salt Lake City | Utah | 84107 | — |
| Novartis Investigative Site | Fredericksburg | Virginia | 22401 | — |
| Novartis Investigative site | Newport News | Virginia | 23606 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
| Novartis Investigator Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01089127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2011 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01089127 live on ClinicalTrials.gov.